Recently, ERβ has been reported to exhibit significantly higher expression in follicular thyroid adenoma than in follicular thyroid cancer (FTC), and to be a stronger differential diagnostic marker than Ki-67 [37]. Here, ESR2 is linked to thyroid gland follicular carcinoma.